Skip to Main Content

Paper Details

Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: Preclinical investigation with the anti-p53 drug, PK11007.
Cancer Lett
40
2018
Author NameAffiliation
Rut KlingerConway Institute, University College Dublin
Darran P O'ConnorRoyal College of Surgeons Ireland
William M GallagherConway Institute, University College Dublin
Alan R FershtMedical Research Council Laboratory of Molecular Biology
  • 1 - 4

Datasets

Dataset
Description
Source Link
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Release 1.2